Logos Global Management LP Vista Gen Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.88 - $1.73 $880,000 - $1.73 Million
-1,000,000 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.14 - $2.09 $1.14 Million - $2.09 Million
-1,000,000 Reduced 50.0%
1,000,000 $1.24 Million
Q4 2021

Feb 14, 2022
BUY
$1.67 - $2.76 $3.34 Million - $5.52 Million
2,000,000 New
2,000,000 $3.9 Million

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $585M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email